Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Buys Ionalytics; Company s Technology Sold With Rival ABI s Mass Spec

NEW YORK, Aug. 11 (GenomeWeb News) - Thermo Electron has acquired Ionalytics, a manufacturer of an ion-filtering device that enhances mass-spectrometer performance, for an undisclosed sum.

 

Currently, the technology, which is said to accelerate drug-discovery research, is marketed with mass spectrometers made by Thermo rivals Applied Biosystems and MDS Sciex. That deal, penned in November 2004, calls for MS Vision to sell and service Ionalytics' Selectra technology in Europe with ABI/MDS' API 300, 365, and 3000.

 

In a statement today, Thermo did not mention that collaboration.

 

Selectra enhances mass-spectrometer performance by providing an additional dimension of ion separation, Ionalytics said in November. Based on FAIMS technology, Selectra transmits a targeted subset of ions into a mass spectrometer, resulting in improved detection limits, increased selectivity, and increased throughput, the company said.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.